Sarepta’s $400M Pivot, MiNK’s 500% Surge, and…

Jul 18

3

1

Layoffs, CRLs, and standout trial data from Sarepta, MiNK, SELLAS, DiaMedica, and more (July 11–17, 2025).

Read →

1 Comment

Saul

Jul 18

The Sarepta story is pretty fast moving-management has not acted creditably to say the least.

Expand full comment

Reply

Share

#nojs-banner { position: fixed; bottom: 0; left: 0; padding: 16px 16px 16px 32px; width: 100%; box-sizing: border-box; background: red; color: white; font-family: -apple-system, "Segoe UI", Roboto, Helvetica, Arial, sans-serif, "Apple Color Emoji", "Segoe UI Emoji", "Segoe UI Symbol"; font-size: 13px; line-height: 13px; } #nojs-banner a { color: inherit; text-decoration: underline; } This site requires JavaScript to run correctly. Please turn on JavaScript or unblock scripts

Biotech Blueprint

Sarepta’s $400M Pivot, MiNK’s 500% Surge, and…